Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment Versus Glimepiride Both in Combination With Metformin

NCT01425580 is registered in ClinicalTrials.gov with Thomas Nystrom as lead sponsor.

NCT NCT01425580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment Versus Glimepiride Both in Combination With Metformin
Lead sponsor
Thomas Nystrom
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
August 31, 2016
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, type 2 diabetes mellitus